Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Rev. SOCERJ ; 10(3): 139-51, jul. 1997.
Article in Portuguese | LILACS | ID: lil-248215

ABSTRACT

O diagnóstico correto do tipo de arritmia cardíaca é a primeira etapa na avaliação do paciente. A necessidade da terapêutica antiarrítmica deve ser cuidadosamente avaliada para, em seguida, decidir se a abordagem será farmacológica ou não. A escolha do fármaco antiarrítmico deve ser individualizada, considerando-se a farmacocinética e as interaçöes medicamentosas. A identificação e correção de condiçöes associadas (isquemia miocárdica, disfunção ventricular, distúrbios eletrolíticos) e a avalização periódica da função dos órgãos responsáveis pela metabolização e excreção das drogas são fundamentais para minimizar os efeitos pró-arrítmicos.


Subject(s)
Humans , Anti-Arrhythmia Agents/classification , Anti-Arrhythmia Agents/pharmacology , Disopyramide/blood , Glycoproteins/adverse effects , Lidocaine/administration & dosage , Procainamide/administration & dosage , Quinidine/administration & dosage , Bretylium Tosylate/administration & dosage , Phenytoin/administration & dosage , Flecainide/administration & dosage , Mexiletine/adverse effects , Moricizine/adverse effects , Sotalol/administration & dosage , Tocainide
3.
Article in English | IMSEAR | ID: sea-34232

ABSTRACT

Pharmacokinetics of quinine, quinidine and cinchonine when given as a combination were evaluated in Thai patients with falciparum malaria during acute infection and convalescence. The combination of quinine, quinidine and cinchonine was randomly given to thirteen patients at 400 mg or 600 mg (consisting of one-third of each component; 7 patients were enrolled in 400 mg regimen and 6 in 600 mg regimen) intravenously every 8 hours for 7 days. The drug combination was given again at day 35 to define the pharmacokinetics of each drug during convalescence. All patients with the 600 mg regimen had good response with 100% cure rate while patients with the 400 mg regimen had a good initial response but one patient recrudesed on day 46. This particular patient had plasma concentrations of all three drugs lower than the mean values of patients with sensitive responses. The plasma levels of quinine and quinidine obtained from the present study were higher than that expected from one-third of the conventional dose (600 mg) when given alone, suggesting drug combination interaction. The terminal half-lives of each of the three components were prolonged during acute malaria when compared to those obtained during convalescence.


Subject(s)
Adult , Antimalarials/administration & dosage , Cinchona Alkaloids/administration & dosage , Drug Combinations , Humans , Malaria, Falciparum/blood , Male , Quinidine/administration & dosage , Quinine/administration & dosage , Treatment Outcome
4.
Article in English | IMSEAR | ID: sea-112153

ABSTRACT

Blood schizontocidal activity of quinine and quinidine has been compared against sensitive as well as chloroquine/mefloquine/quinine resistant strains of Plasmodium berghei and a multiple resistant strain of P. yoelii nigeriensis in Swiss mice. Evaluation of results on ED50/ED90 basis has shown distinct superiority of quinidine over quinine against sensitive as well as drug resistant strain of rodent malaria.


Subject(s)
Animals , Drug Evaluation, Preclinical , Drug Resistance , Malaria/blood , Mice , Plasmodium berghei , Plasmodium yoelii , Quinidine/administration & dosage , Quinine/administration & dosage
6.
Non-conventional in Spanish | LILACS | ID: lil-113258

ABSTRACT

Analiza la acción farmacológica, efectividad, dosis de administración y efectos colaterales de diversas drogas antiarrítmicas clasificadas del acuerdo a sus efectos electrofisiológicos (quinidina y procainamida, disopiramida, agentes betabloqueantes, mexiletine, amiodarona, y, verapamil), y suelen indicarse para el tratamiento de la insuficiencia cardíaca, las arritmias y los trastornos de conducción en pacientes chagásicos


Subject(s)
Humans , Anti-Arrhythmia Agents , Amiodarone/therapeutic use , Arrhythmias, Cardiac/drug effects , Chagas Cardiomyopathy/drug therapy , Chagas Disease/therapy , Digitalis , Disopyramide/therapeutic use , Mexiletine/therapeutic use , Procainamide/therapeutic use , Quinidine/therapeutic use , Verapamil/therapeutic use , Amiodarone/administration & dosage , Amiodarone/adverse effects , Disopyramide/administration & dosage , Disopyramide/adverse effects , Mexiletine/administration & dosage , Mexiletine/adverse effects , Procainamide/adverse effects , Procainamide/therapeutic use , Quinidine/administration & dosage , Quinidine/adverse effects , Verapamil/administration & dosage , Verapamil/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL